BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2331440)

  • 1. Haemoglobin adducts formed by aromatic amines in smokers: sources of inter-individual variability.
    Ronco G; Vineis P; Bryant MS; Skipper PL; Tannenbaum SR
    Br J Cancer; 1990 Apr; 61(4):534-7. PubMed ID: 2331440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haemoglobin adducts of aromatic amines in people exposed to cigarette smoke.
    Bryant MS; Vineis P; Skipper PL; Tannenbaum SR
    IARC Sci Publ; 1988; (89):133-6. PubMed ID: 3198197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CYP1A2 and NAT2 phenotyping and 3-aminobiphenyl and 4-aminobiphenyl hemoglobin adduct levels in smokers and non-smokers.
    Sarkar M; Stabbert R; Kinser RD; Oey J; Rustemeier K; von Holt K; Schepers G; Walk RA; Roethig HJ
    Toxicol Appl Pharmacol; 2006 Jun; 213(3):198-206. PubMed ID: 16405939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of 4-aminobiphenyl hemoglobin adducts in smokers and nonsmokers by pseudo capillary on-column gas chromatography- tandem mass spectrometry.
    Seyler TH; Reyes LR; Bernert JT
    J Anal Toxicol; 2010; 34(6):304-11. PubMed ID: 20663282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of biomarkers in epidemiology: the example of bladder cancer.
    Vineis P
    Toxicol Lett; 1992 Dec; 64-65 Spec No():463-7. PubMed ID: 1471198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of carcinogenic aromatic amines in the urine of non-smokers.
    Grimmer G; Dettbarn G; Seidel A; Jacob J
    Sci Total Environ; 2000 Feb; 247(1):81-90. PubMed ID: 10721145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemoglobin adducts of aromatic amines: associations with smoking status and type of tobacco.
    Bryant MS; Vineis P; Skipper PL; Tannenbaum SR
    Proc Natl Acad Sci U S A; 1988 Dec; 85(24):9788-91. PubMed ID: 3200858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 4-Aminobiphenyl hemoglobin adducts in fetuses exposed to the tobacco smoke carcinogen in utero.
    Coghlin J; Gann PH; Hammond SK; Skipper PL; Taghizadeh K; Paul M; Tannenbaum SR
    J Natl Cancer Inst; 1991 Feb; 83(4):274-80. PubMed ID: 1994056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of three carcinogenic aromatic amines in urine of smokers and nonsmokers.
    Riedel K; Scherer G; Engl J; Hagedorn HW; Tricker AR
    J Anal Toxicol; 2006 Apr; 30(3):187-95. PubMed ID: 16803653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HPLC and GC/MS determination of 4-aminobiphenyl haemoglobin adducts in fetuses exposed to the tobacco smoke carcinogen in utero.
    Pinorini-Godly MT; Myers SR
    Toxicology; 1996 Mar; 107(3):209-17. PubMed ID: 8604481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular dosimetry of aromatic amines in human populations.
    Skipper PL; Tannenbaum SR
    Environ Health Perspect; 1994 Oct; 102 Suppl 6(Suppl 6):17-21. PubMed ID: 7889842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of 4-aminobiphenyl-hemoglobin adducts in lung cancer cases and controls.
    Weston A; Caporaso NE; Taghizadeh K; Hoover RN; Tannenbaum SR; Skipper PL; Resau JH; Trump BF; Harris CC
    Cancer Res; 1991 Oct; 51(19):5219-23. PubMed ID: 1913645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bulky DNA adducts, 4-aminobiphenyl-haemoglobin adducts and diet in the European Prospective Investigation into Cancer and Nutrition (EPIC) prospective study.
    Peluso M; Airoldi L; Munnia A; Colombi A; Veglia F; Autrup H; Dunning A; Garte S; Gormally E; Malaveille C; Matullo G; Overvad K; Raaschou-Nielsen O; Clavel-Chapelon F; Linseisen J; Boeing H; Trichopoulou A; Palli D; Krogh V; Tumino R; Panico S; Bueno-De-Mesquita BH; Peeters PH; Kumle M; Agudo A; Martinez C; Dorronsoro M; Barricarte A; Tormo MJ; Quiros JR; Berglund G; Jarvholm B; Day NE; Key TJ; Saracci R; Kaaks R; Riboli E; Bingham S; Vineis P
    Br J Nutr; 2008 Sep; 100(3):489-95. PubMed ID: 18275627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytochrome P4501A2: enzyme induction and genetic control in determining 4-aminobiphenyl-hemoglobin adduct levels.
    Landi MT; Zocchetti C; Bernucci I; Kadlubar FF; Tannenbaum S; Skipper P; Bartsch H; Malaveille C; Shields P; Caporaso NE; Vineis P
    Cancer Epidemiol Biomarkers Prev; 1996 Sep; 5(9):693-8. PubMed ID: 8877060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haemoglobin adducts from aromatic amines and tobacco specific nitrosamines in pregnant smoking and non smoking women.
    Birgit Branner Cornelia Kutzer Wolfgang Wickenpflug Gerhard Scherer Wolf-Dieter Heller Elmar Richter
    Biomarkers; 1998; 3(1):35-47. PubMed ID: 23899255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of 4-aminobiphenyl-hemoglobin adducts in maternal and fetal blood-samples.
    Myers SR; Spinnato JA; Pinorini-Godly MT; Cook C; Boles B; Rodgers GC
    J Toxicol Environ Health; 1996 Apr; 47(6):553-66. PubMed ID: 8614023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemoglobin adducts of 4-aminobiphenyl in smokers and nonsmokers.
    Bryant MS; Skipper PL; Tannenbaum SR; Maclure M
    Cancer Res; 1987 Jan; 47(2):602-8. PubMed ID: 3791245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alkylaniline-hemoglobin adducts and risk of non-smoking-related bladder cancer.
    Gan J; Skipper PL; Gago-Dominguez M; Arakawa K; Ross RK; Yu MC; Tannenbaum SR
    J Natl Cancer Inst; 2004 Oct; 96(19):1425-31. PubMed ID: 15467031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-acetylcysteine treatment lowers 4-aminobiphenyl haemoglobin adduct levels in non-smokers.
    Rösler S; Behr J; Richter E
    Eur J Cancer Prev; 1999 Oct; 8(5):469-72. PubMed ID: 10548405
    [No Abstract]   [Full Text] [Related]  

  • 20. Interindividual variation in carcinogen metabolism and bladder cancer risk.
    Vineis P; Ronco G
    Environ Health Perspect; 1992 Nov; 98():95-9. PubMed ID: 1486869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.